Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Wolf

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
The Prostate|November 26, 2009
Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancerPhilipp Wolf, Nikolaus Freudenberg, Patrick Bühler, et al.
Journal of Cancer|October 20, 2023
Synergistic Cytotoxicity of a Toxin Targeting the Epidermal Growth Factor Receptor and the Glycosylated Triterpenoid SO1861 in Prostate CancerAlexandra Fischer, Anie Priscilla Masilamani, Susanne Schultze-Seemann, et al.
Macromolecular Bioscience|April 12, 2012
Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugatesJihua Liu, Pavla Kopečková, Huaizhong Pan, et al.
Molecular Pharmaceutics|April 7, 2009
Biorecognition and subcellular trafficking of HPMA copolymer-anti-PSMA antibody conjugates by prostate cancer cellsJihua Liu, Pavla Kopecková, Patrick Bühler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancerPhilipp Wolf, Karen Alt, David Wetterauer, et al.
Cancer Genomics & Proteomics|June 29, 2024
Photoimmunotherapy of HER2-expressing Breast Cancer CellsLukas Klemenz, Isis Wolf, Jonas Storz, et al.
The Prostate|August 6, 2010
High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMAKaren Alt, Stefan Wiehr, Walter Ehrlichmann, et al.
Toxins|November 29, 2013
Activation of RhoA,B,C by Yersinia Cytotoxic Necrotizing Factor (CNFy) induces apoptosis in LNCaP prostate cancer cellsAnke Augspach, Joachim H List, Philipp Wolf, et al.
Nature Chemistry|December 8, 2020
Live cell PNA labelling enables erasable fluorescence imaging of membrane proteinsGeorgina C Gavins, Katharina Gröger, Michael D Bartoschek, et al.
In Vivo (Athens, Greece)|February 2, 2011
In vivo testing of 177Lu-labelled anti-PSMA antibody as a new radioimmunotherapeutic agent against prostate cancerMartin Behe, Karen Alt, Friederike Deininger, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
The Prostate|November 26, 2009
Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancerPhilipp Wolf, Nikolaus Freudenberg, Patrick Bühler, et al.
Journal of Cancer|October 20, 2023
Synergistic Cytotoxicity of a Toxin Targeting the Epidermal Growth Factor Receptor and the Glycosylated Triterpenoid SO1861 in Prostate CancerAlexandra Fischer, Anie Priscilla Masilamani, Susanne Schultze-Seemann, et al.
Macromolecular Bioscience|April 12, 2012
Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugatesJihua Liu, Pavla Kopečková, Huaizhong Pan, et al.
Molecular Pharmaceutics|April 7, 2009
Biorecognition and subcellular trafficking of HPMA copolymer-anti-PSMA antibody conjugates by prostate cancer cellsJihua Liu, Pavla Kopecková, Patrick Bühler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancerPhilipp Wolf, Karen Alt, David Wetterauer, et al.
Cancer Genomics & Proteomics|June 29, 2024
Photoimmunotherapy of HER2-expressing Breast Cancer CellsLukas Klemenz, Isis Wolf, Jonas Storz, et al.
The Prostate|August 6, 2010
High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMAKaren Alt, Stefan Wiehr, Walter Ehrlichmann, et al.
Toxins|November 29, 2013
Activation of RhoA,B,C by Yersinia Cytotoxic Necrotizing Factor (CNFy) induces apoptosis in LNCaP prostate cancer cellsAnke Augspach, Joachim H List, Philipp Wolf, et al.
Nature Chemistry|December 8, 2020
Live cell PNA labelling enables erasable fluorescence imaging of membrane proteinsGeorgina C Gavins, Katharina Gröger, Michael D Bartoschek, et al.
In Vivo (Athens, Greece)|February 2, 2011
In vivo testing of 177Lu-labelled anti-PSMA antibody as a new radioimmunotherapeutic agent against prostate cancerMartin Behe, Karen Alt, Friederike Deininger, et al.
Pageof 8